Phase 3 N=149 Alkali Therapy in Chronic Kidney Disease
Chronic Kidney Disease · Metabolic Acidosis
Primary: Sit to Stand to Sit Speed: Time Taken to Sit to Stand to Sit 10 Times — 23.8; 22.9 seconds
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=45 Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy
Radiation Toxicity · Recurrent Breast Cancer · Stage I Breast Cancer
Primary: Acute and Grade 2 or Higher Radiation-related Skin Toxicity as Assessed by Common Terminology Criteria for Adverse Events (CTCAE) Version 3.0 — 38; 38 percentage of…
N/A N=171 Effect of Potassium Bicarbonate Supplementation on Bone and Muscle in Older Adults
Osteoporosis · Sarcopenia
Primary: Biochemical Markers of Bone Turnover — -6.25; -3.36; -0.14; 0.5 nmol/mmol
Phase 3 N=10 Chronic Versus Acute Dosing of Sodium Citrate for Swimming 200m
Alkalosis
Primary: Time — 144.2; 145.3; 145.3; 144.8 seconds
Phase 2 N=244 Musculoskeletal Effects of Bicarbonate
Muscle Loss · Fractures · Osteoporosis, Age Related
Primary: The Dose of Potassium Bicarbonate Needed for Maximal Suppression of 24-hr Urinary N-telopeptide — 240; 230; 241; -53 nmol/day
N/A N=109 Bicarbonate Administration in CKD
Chronic Kidney Disease · Metabolic Acidosis
Primary: Change in Brachial Artery Flow Mediated Dilation — 3.99; 3.78; 4.25; 4.43 percentage